Company intelligence / Profile preview

NICO Corporation

Indianapolis, Indiana, United Statesniconeuro.com ↗

Ownership: Private
Employees: ~175
Development stage: Commercial

Overview

NICO’s minimally invasive parafascicular surgery approach demonstrated improved functional and economic outcomes for intracerebral hemorrhage in the ENRICH randomized controlled trial, including a significant reduction in 30-day mortality compared to standard medical management. The company’s technologies are widely adopted for brain tumor removal and stroke care, with over 50,000 patients treated.

Therapeutic areas: OncologyNeurology
Modalities: Device (minimally invasive neurosurgical devices and systems)
Industry: Surgical Medical Devices

Partnerships

Emory University – clinical partner on the ENRICH trial; multiple academic collaborations on tissue preservation studies.

Beyond the preview

Go deeper on NICO Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NICO Corporation.

Explore the full profile